Sherlock Biosciences — Operating Costs & STI Clinical Trial
$2M
Source
Notes
[Scientific Research] Open Philanthropy recommended an investment of $1,500,000 in Sherlock Biosciences. Sherlock will use the funds to cover its operating costs, as well as to expand data collection in an ongoing clinical trial evaluating Sherlock’s disposable over-the-counter STI tests against PCR tests (currently the gold standard). This falls within our focus area of scientific research.
Other Grants by Coefficient Giving
2626Showing 10 of 2626 grants
Other Grants to Sherlock Biosciences
1| Grant | Funder | Recipient | Amount | Date |
|---|---|---|---|---|
| Grant to "support the development of universal CRISPR-based diagnostics, including paper-based diagnostics that can be used in developing-country settings without electricity." | FTX Future Fund | Sherlock Biosciences | $2M | Feb 2022 |